Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""RESPIRATORY syncytial virus"" wg kryterium: Temat


Tytuł :
Human Coronavirus NL63 Among Other Respiratory Viruses in Clinical Specimens of Egyptian Children and Raw Sewage Samples.
Autorzy :
El-Senousy WM; Environmental Virology Lab, Water Pollution Research Department, Environmental Research Division and Food-Borne Viruses Group, Centre of Excellence for Advanced Sciences, National Research Centre (NRC), 33 El-Buhouth st., Dokki, Giza, 12622, Egypt. .
Shouman M; Pediatric Department, Centre of Medical Excellence, Medical Research Division, NRC, Dokki, Giza, Egypt.
Pokaż więcej
Źródło :
Food and environmental virology [Food Environ Virol] 2021 Sep; Vol. 13 (3), pp. 322-328. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenoviridae*
Coronavirus NL63, Human*
Parainfluenza Virus 1, Human*
Respiratory Syncytial Virus, Human*
Coronavirus Infections/*virology
Respiratory Tract Infections/*virology
Sewage/*virology
Adenoviridae Infections/virology ; Child, Preschool ; Cities ; Egypt/epidemiology ; Humans ; Infant ; Polymerase Chain Reaction ; Respiratory Syncytial Virus Infections/virology ; Respirovirus Infections/virology ; Specimen Handling ; Viruses
Czasopismo naukowe
Tytuł :
A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
Autorzy :
Blunck BN; Department of Molecular Virology and Microbiology, United States.
Aideyan L; Department of Molecular Virology and Microbiology, United States.
Ye X; Department of Molecular Virology and Microbiology, United States.
Avadhanula V; Department of Molecular Virology and Microbiology, United States.
Ferlic-Stark L; Department of Molecular Virology and Microbiology, United States.
Zechiedrich L; Department of Molecular Virology and Microbiology, United States; Verna and Marrs McLean, Department of Biochemistry and Molecular Biology, United States; Department of Pharmacology and Chemical Biology, United States.
Gilbert BE; Department of Molecular Virology and Microbiology, United States.
Piedra PA; Department of Molecular Virology and Microbiology, United States; Department of Pediatrics, Baylor College of Medicine, United States. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Feb 22; Vol. 39 (8), pp. 1248-1256. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Humoral*
Respiratory Syncytial Virus Vaccines*
Respiratory Syncytial Virus Infections/*immunology
Adult ; Antibodies, Neutralizing ; Antibodies, Viral ; Humans ; Kinetics ; Prospective Studies ; Respiratory Syncytial Virus, Human ; Texas/epidemiology ; Viral Fusion Proteins/immunology
Czasopismo naukowe
Tytuł :
Indole-3-carboxaldehyde regulates RSV-induced inflammatory response in RAW264.7 cells by moderate inhibition of the TLR7 signaling pathway.
Autorzy :
Hou X; College of Pharmacy, Nanjing University of Chinese Medicine Hanlin College, No. 6 Xueyuan Road, Taizhou, 225300, China.
Zhang X; Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Bi J; Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Zhu A; College of Pharmacy, Nanjing University of Chinese Medicine Hanlin College, No. 6 Xueyuan Road, Taizhou, 225300, China.
He L; College of Pharmacy, Nanjing University of Chinese Medicine Hanlin College, No. 6 Xueyuan Road, Taizhou, 225300, China. .; Nanjing University of Chinese Medicine, Nanjing, 210023, China. .
Pokaż więcej
Źródło :
Journal of natural medicines [J Nat Med] 2021 Jun; Vol. 75 (3), pp. 602-611. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji :
Journal Article
MeSH Terms :
Respiratory Syncytial Virus, Human*
Signal Transduction*
Antiviral Agents/*pharmacology
Indoles/*pharmacology
Macrophages/*drug effects
Membrane Glycoproteins/*metabolism
Toll-Like Receptor 7/*metabolism
Alkaloids/pharmacology ; Animals ; Down-Regulation ; Drugs, Chinese Herbal/pharmacology ; Interferon-alpha/metabolism ; Mice ; RAW 264.7 Cells ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus Infections/metabolism
Czasopismo naukowe
Tytuł :
Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination.
Autorzy :
van Boven M; Centre for Infectious Disease Control, National institute for Public Health and the Environment, Bilthoven, the Netherlands.
Teirlinck AC; Centre for Infectious Disease Control, National institute for Public Health and the Environment, Bilthoven, the Netherlands.
Meijer A; Centre for Infectious Disease Control, National institute for Public Health and the Environment, Bilthoven, the Netherlands.
Hooiveld M; Nivel, Utrecht, the Netherlands.
van Dorp CH; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
Reeves RM; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Campbell H; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
van der Hoek W; Centre for Infectious Disease Control, National institute for Public Health and the Environment, Bilthoven, the Netherlands.
Pokaż więcej
Corporate Authors :
RESCEU Investigators
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Oct 07; Vol. 222 (Suppl 7), pp. S688-S694.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Respiratory Syncytial Virus Vaccines*
Vaccination*
Respiratory Syncytial Virus Infections/*prevention & control
Respiratory Syncytial Virus Infections/*transmission
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Hospitalization ; Humans ; Immunity ; Incidence ; Infant ; Middle Aged ; Netherlands ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus, Human/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
Autorzy :
Wildenbeest JG; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Zuurbier RP; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.; Spaarne Gasthuis Academy, Hoofddorp and Haarlem, The Netherlands.
Korsten K; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
van Houten MA; Spaarne Gasthuis Academy, Hoofddorp and Haarlem, The Netherlands.
Billard MN; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Derksen-Lazet N; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Drysdale SB; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Heikkinen T; Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.
Cunningham S; Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
Leach A; GlaxoSmithKline, Rockville, Maryland, USA.
Martinón-Torres F; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Genetics, Vaccines and Infections Research Group, Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain.
Rodríguez-Tenreiro Sánchez C; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Gómez-Carballa A; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Genetics, Vaccines and Infections Research Group, Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Spain.
Bont LJ; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Corporate Authors :
RESCEU Investigators
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Oct 07; Vol. 222 (Suppl 7), pp. S606-S612.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Respiratory Syncytial Virus, Human*/isolation & purification
Hospitalization/*statistics & numerical data
Respiratory Syncytial Virus Infections/*epidemiology
Respiratory Syncytial Virus Infections/*virology
Biomarkers ; Cohort Studies ; Europe/epidemiology ; Humans ; Incidence ; Infant ; Prospective Studies ; Respiratory Syncytial Virus Infections/diagnosis ; Respiratory Syncytial Virus Infections/prevention & control ; Respiratory Syncytial Virus Vaccines ; Respiratory Tract Infections/epidemiology ; Respiratory Tract Infections/virology ; Risk Factors
Czasopismo naukowe
Tytuł :
Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018.
Autorzy :
Demont C; Sanofi Pasteur, 14 Espace Henry Vallée, 69007, Lyon, France. .
Petrica N; IQVIA, 92400, Courbevoie, France.
Bardoulat I; IQVIA, 92400, Courbevoie, France.
Duret S; IQVIA, 92400, Courbevoie, France.
Watier L; Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France.
Chosidow A; Department of Pediatrics, Armand Trousseau Hospital (AP-HP), 75012, Paris, France.
Lorrot M; Department of Pediatrics, Armand Trousseau Hospital (AP-HP), 75012, Paris, France.
Kieffer A; Sanofi Pasteur, 14 Espace Henry Vallée, 69007, Lyon, France.
Lemaitre M; IQVIA, 92400, Courbevoie, France.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Aug 02; Vol. 21 (1), pp. 730. Date of Electronic Publication: 2021 Aug 02.
Typ publikacji :
Journal Article
MeSH Terms :
Respiratory Syncytial Virus Infections/*economics
Child, Preschool ; Cost of Illness ; Female ; France/epidemiology ; Hospitalization/economics ; Humans ; Infant ; Infant, Newborn ; Male ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Virus Infections/therapy ; Respiratory Syncytial Virus, Human ; Retrospective Studies ; Seasons
Czasopismo naukowe
Tytuł :
Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
Autorzy :
Rahman F; Department of Biology, College of Science, University of Sulaimani, Kurdistan Region, Iraq.; Department of Molecular Biology, High Quality Laboratory, Anwar Sheikha Medical City, Sulaymaniyah, Iraq.
Libre C; Cancer Research Center of Lyon, INSERM U1052 UMR CNRS 5286, Equipe labellisée Ligue Contre le Cancer, Université de Lyon, 69008 Lyon, France.
Oleinikov A; Charles E. Schmidt College of Medicine, Department of Biomedical Science, Florida Atlantic University, 777 Glades Rd, Boca Raton, FL, 33431, USA.
Tcherniuk S; Unité de Virologie et Immunologie Moléculaires, INRA, Université Paris SaclayJouy-en-Josas, France.; Department of Biological Sciences, Youth Academy of Sciences, Kiev, Ukraine.
Pokaż więcej
Źródło :
The Journal of general virology [J Gen Virol] 2021 Aug; Vol. 102 (8).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*pharmacology
Chloroquine/*pharmacology
Pyrimethamine/*pharmacology
Respiratory Syncytial Virus, Human/*drug effects
Virus Replication/*drug effects
Animals ; Cell Line ; Cell Survival/drug effects ; Disease Models, Animal ; Female ; Humans ; Immunocompromised Host ; Mice ; Mice, Inbred BALB C ; Respiratory Syncytial Virus Infections/drug therapy ; Respiratory Syncytial Virus Infections/virology ; Ribavirin/pharmacology
Czasopismo naukowe
Tytuł :
European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test.
Autorzy :
Wolters F; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Grünberg M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Huber M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Kessler HH; Molecular Diagnostics Laboratory, Diagnostic and Research Institute of Hygiene, Microbiology, and Environmental Medicine, Medical University of Graz, Graz, Austria.
Prüller F; Clinical Institute of Medical and Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
Saleh L; Institute of Clinical Chemistry, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
Fébreau C; Department of Virology, University Hospital of Rennes, Rennes, France.
Rahamat-Langendoen J; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Thibault V; Department of Virology, University Hospital of Rennes, Rennes, France.
Melchers WJG; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Oct; Vol. 93 (10), pp. 5798-5804. Date of Electronic Publication: 2021 Jun 06.
Typ publikacji :
Evaluation Study; Journal Article; Multicenter Study
MeSH Terms :
Influenza A virus/*isolation & purification
Influenza B virus/*isolation & purification
Respiratory Syncytial Virus, Human/*isolation & purification
Respiratory Tract Infections/*diagnosis
SARS-CoV-2/*isolation & purification
COVID-19/diagnosis ; COVID-19 Nucleic Acid Testing ; Europe/epidemiology ; Humans ; Influenza, Human/diagnosis ; Molecular Diagnostic Techniques ; Multiplex Polymerase Chain Reaction ; Nasopharynx/virology ; Respiratory Syncytial Virus Infections/diagnosis ; Respiratory Tract Infections/virology ; SARS-CoV-2/genetics ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model.
Autorzy :
Rhodin MHJ; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
McAllister NV; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Castillo J; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Noton SL; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Fearns R; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Kim IJ; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Yu J; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Blaisdell TP; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Panarese J; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Shook BC; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Or YS; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Goodwin B; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Lin K; Enanta Pharmaceuticals Inc., Watertown, Massachusetts, United States of America.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2021 Mar 15; Vol. 17 (3), pp. e1009428. Date of Electronic Publication: 2021 Mar 15 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Respiratory Syncytial Virus Infections*
Antiviral Agents/*pharmacology
Animals ; Cell Line ; Chlorocebus aethiops ; Disease Models, Animal ; Epithelial Cells/drug effects ; Epithelial Cells/virology ; Humans ; Respiratory Mucosa/drug effects ; Respiratory Mucosa/virology ; Respiratory Syncytial Virus, Human/drug effects
Czasopismo naukowe
Tytuł :
Pharmacological management of human respiratory syncytial virus infection.
Autorzy :
Kalergis AM; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.; Departamento De Endocrinología, Facultad De Medicina, Pontificia Universidad Católica De Chile , Santiago, Chile.
Soto JA; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Gálvez NMS; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Andrade CA; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Fernandez A; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Bohmwald K; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Bueno SM; Millennium Institute on Immunology and Immunotherapy, Departamento De Genética Molecular Y Microbiología, Facultad De Ciencias Biológicas, Pontificia Universidad Católica De Chile , Santiago, Chile.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Dec; Vol. 21 (18), pp. 2293-2303. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Respiratory Syncytial Virus Vaccines*
Adrenal Cortex Hormones/*therapeutic use
Antiviral Agents/*therapeutic use
Bronchodilator Agents/*therapeutic use
Respiratory Syncytial Virus Infections/*drug therapy
Respiratory Syncytial Virus, Human/*drug effects
Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/adverse effects ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/adverse effects ; Humans ; Palivizumab/administration & dosage ; Palivizumab/adverse effects ; Palivizumab/therapeutic use ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus Infections/prevention & control ; Respiratory Syncytial Virus Infections/virology ; Respiratory Syncytial Virus, Human/immunology ; Viral Proteins/antagonists & inhibitors ; Viral Proteins/immunology
Czasopismo naukowe
Tytuł :
The journey to a respiratory syncytial virus vaccine.
Autorzy :
Mejias A; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio; Division of Pediatric Infectious Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio; Departamento de Farmacologia y Pediatria, Facultad de Medicina, Universidad de Malaga, Malaga, Spain. Electronic address: .
Rodríguez-Fernández R; Department of Pediatrics, Hospital Infantil Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Oliva S; Division of Pediatric Emergency Medicine and Critical Care, Hospital Regional Universitario de Malaga, Malaga, Spain; Departamento de Farmacologia y Pediatria, Facultad de Medicina, Universidad de Malaga, Malaga, Spain.
Peeples ME; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
Ramilo O; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio; Division of Pediatric Infectious Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio.
Pokaż więcej
Źródło :
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2020 Jul; Vol. 125 (1), pp. 36-46. Date of Electronic Publication: 2020 Mar 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Respiratory Syncytial Virus Vaccines*
Respiratory Syncytial Virus Infections/*prevention & control
Female ; Humans ; Male ; Respiratory Syncytial Virus, Human/immunology
Czasopismo naukowe
Tytuł :
Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma.
Autorzy :
Raita Y; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. .
Pérez-Losada M; Computational Biology Institute, Department of Biostatistics and Bioinformatics, The George Washington University, Washington, DC, USA.; CIBIO-InBIO, Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, Campus Agrário de Vairão, Vairão, Portugal.
Freishtat RJ; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.; Division of Emergency Medicine, Children's National Hospital, Washington, DC, USA.; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Harmon B; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.
Mansbach JM; Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Piedra PA; Departments of Molecular Virology and Microbiology and Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Zhu Z; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Camargo CA; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Hasegawa K; Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Jun 14; Vol. 12 (1), pp. 3601. Date of Electronic Publication: 2021 Jun 14.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Asthma/*complications
Asthma/*virology
Bronchiolitis, Viral/*complications
Bronchiolitis, Viral/*virology
Respiratory Syncytial Virus Infections/*complications
Respiratory Syncytial Virus Infections/*virology
Asthma/epidemiology ; Female ; Gene Expression ; Genetic Predisposition to Disease ; Hospitalization ; Humans ; Infant ; Male ; Metabolome ; Microbiota ; Prospective Studies ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Virus, Human/genetics ; Respiratory System ; Rhinovirus ; Risk Factors ; Transcriptome ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Balancing precision versus cohort transcriptomic analysis of acute and recovery phase of viral bronchiolitis.
Autorzy :
Gupta R; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.
Leimanis ML; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Pediatric Intensive Care Unit, Helen DeVos Children's Hospital, Grand Rapids, Michigan.
Adams M; Genomics Core Facility, Van Andel Institute, Grand Rapids, Michigan.
Bachmann AS; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.
Uhl KL; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.
Bupp CP; Spectrum Health Medical Genetics, Grand Rapids, Michigan.
Hartog NL; Allergy & Immunology, Spectrum Health, Grand Rapids, Michigan.
Kort EJ; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; DeVos Cardiovascular Research Program, Spectrum Health and Van Andel Institute, Grand Rapids, Michigan.
Olivero R; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Infectious Disease, Helen DeVos Children's Hospital, Grand Rapids, Michigan.
Comstock SS; Department of Food Science and Human Nutrition, Michigan State University, East Lansing, Michigan.
Sanfilippo DJ; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Pediatric Intensive Care Unit, Helen DeVos Children's Hospital, Grand Rapids, Michigan.
Lunt SY; Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan.; Chemical Engineering and Materials Science, Michigan State University, East Lansing, Michigan.
Prokop JW; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.
Rajasekaran S; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.; Pediatric Intensive Care Unit, Helen DeVos Children's Hospital, Grand Rapids, Michigan.; Office of Research, Spectrum Health, Grand Rapids, Michigan.
Pokaż więcej
Źródło :
American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2021 Jun 01; Vol. 320 (6), pp. L1147-L1157. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Bronchiolitis, Viral/*virology
Minor Histocompatibility Antigens/*pharmacology
Respiratory Syncytial Virus Infections/*drug therapy
Transcriptome/*drug effects
Bronchiolitis, Viral/blood ; Humans ; Respiratory Syncytial Virus Infections/immunology ; Respiratory Syncytial Virus, Human/drug effects ; Respiratory Syncytial Virus, Human/pathogenicity ; Severity of Illness Index ; Transcriptome/immunology ; Virus Diseases/drug therapy ; Virus Diseases/virology
Czasopismo naukowe
Tytuł :
A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
Autorzy :
Mueller S; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Stauft CB; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Kalkeri R; Southern Research, Inc., Frederick, MD, United States. Electronic address: .
Koidei F; Southern Research, Inc., Frederick, MD, United States. Electronic address: .
Kushnir A; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Tasker S; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Coleman JR; Codagenix, Inc., Farmingdale, NY, United States. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2020 Mar 23; Vol. 38 (14), pp. 2943-2948. Date of Electronic Publication: 2020 Feb 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Codon*
Respiratory Syncytial Virus Infections*/prevention & control
Respiratory Syncytial Virus Vaccines/*immunology
Animals ; Antibodies, Viral/blood ; Chlorocebus aethiops ; Computer-Aided Design ; Immunity, Cellular ; Immunity, Humoral ; Respiratory Syncytial Virus Vaccines/genetics ; Respiratory Syncytial Virus, Human ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology ; Vero Cells
Czasopismo naukowe
Tytuł :
Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection.
Autorzy :
Brügger M; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Démoulins T; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Barut GT; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Zumkehr B; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Oliveira Esteves BI; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Mehinagic K; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Haas Q; Institute of Pharmacology, University of Bern, Bern, Switzerland.
Schögler A; Department of Biomedical Research, University of Bern, Bern, Switzerland.
Rameix-Welti MA; Université Paris-Saclay, INSERM, Université de Versailles St. Quentin, UMR 1173 (2I), Versailles, France.
Eléouët JF; Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Moehrlen U; Pediatric Surgery, University Children's Hospital Zurich, Zurich, Switzerland.
Marti TM; Department of Biomedical Research, University of Bern, Bern, Switzerland.; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Schmid RA; Department of Biomedical Research, University of Bern, Bern, Switzerland.; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Summerfield A; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Posthaus H; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Ruggli N; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Hall SRR; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Gillies McIndoe Research Institute, Wellington, New Zealand.
Alves MP; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2021 Jul 28; Vol. 17 (7), pp. e1009789. Date of Electronic Publication: 2021 Jul 28 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Acute Lung Injury/*immunology
Acute Lung Injury/*virology
Lung/*immunology
Mesenchymal Stem Cells/*immunology
Respiratory Syncytial Virus Infections/*immunology
Animals ; Humans ; Lung/cytology ; Lung/metabolism ; Mesenchymal Stem Cells/metabolism ; Respiratory Syncytial Virus Infections/metabolism ; Respiratory Syncytial Virus, Human/immunology ; Sheep
Czasopismo naukowe
Tytuł :
Increase in Detection of Respiratory Syncytial Virus Among Older Adults in Arizona : An Association With Changes in Testing Practices.
Autorzy :
Bridge R; 6577 Arizona Department of Health Services, Phoenix, AZ, USA.
Erhart LM; 6577 Arizona Department of Health Services, Phoenix, AZ, USA.
Brady S; 6577 Arizona Department of Health Services, Phoenix, AZ, USA.
Komatsu K; 6577 Arizona Department of Health Services, Phoenix, AZ, USA.
Pokaż więcej
Źródło :
Public health reports (Washington, D.C. : 1974) [Public Health Rep] 2021 Jul-Aug; Vol. 136 (4), pp. 421-427. Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article
MeSH Terms :
Respiratory Syncytial Virus Infections/*diagnostic imaging
Respiratory Syncytial Virus Infections/*epidemiology
Adolescent ; Adult ; Age Distribution ; Aged ; Arizona ; Child ; Child, Preschool ; Fluorescent Antibody Technique ; Humans ; Infant ; Middle Aged ; Patient Discharge ; Polymerase Chain Reaction ; Population Surveillance ; Respiratory Syncytial Virus, Human ; Seasons ; Socioeconomic Factors ; Virus Cultivation ; Young Adult
Czasopismo naukowe
Tytuł :
Designing of Potential Polyvalent Vaccine Model for Respiratory Syncytial Virus by System Level Immunoinformatics Approaches.
Autorzy :
Naqvi STQ; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University Multan, Pakistan.
Yasmeen M; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University Multan, Pakistan.
Ismail M; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University Multan, Pakistan.
Muhammad SA; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University Multan, Pakistan.
Nawazish-I-Husain S; University College of Pharmacy, Punjab University Lahore, Pakistan.
Ali A; ASAB, National University of Sciences and Technology (NUST), Islamabad, Pakistan.
Munir F; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, China.; Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Zhang Q; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, China.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2021 May 28; Vol. 2021, pp. 9940010. Date of Electronic Publication: 2021 May 28 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Respiratory Syncytial Virus, Human*
Computational Biology/*methods
Respiratory Syncytial Virus Infections/*prevention & control
Vaccines, Combined/*therapeutic use
Alleles ; Antigens ; Codon ; Computer Simulation ; Epitopes ; Epitopes, T-Lymphocyte ; Glycoproteins/chemistry ; Histocompatibility Antigens Class I ; Histocompatibility Antigens Class II ; Hospitalization ; Humans ; Immune System ; Molecular Docking Simulation ; Proteasome Endopeptidase Complex ; Protein Interaction Mapping ; Proteomics ; T-Lymphocytes/immunology ; Vaccines ; Viral Fusion Proteins/chemistry
Czasopismo naukowe
Tytuł :
Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies.
Autorzy :
Hu M; Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia; and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
Bogoyevitch MA; Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia; and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
Jans DA; Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria, Australia; and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
Physiological reviews [Physiol Rev] 2020 Oct 01; Vol. 100 (4), pp. 1527-1594. Date of Electronic Publication: 2020 Mar 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Respiratory Syncytial Virus, Human*
Antiviral Agents/*pharmacology
Respiratory Syncytial Virus Infections/*prevention & control
Respiratory Syncytial Virus Infections/*virology
Viral Vaccines/*immunology
Humans ; Respiratory Syncytial Virus Infections/drug therapy ; Respiratory Syncytial Virus Infections/immunology
Czasopismo naukowe
Tytuł :
Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.
Autorzy :
Liang W; Department of Immunology, Hebei Medical University, Shijiazhuang, Hebei, China.; Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Shijiazhuang, Hebei, China.; Department of Pathogen Biology, Hebei Medical University, Shijiazhuang, Hebei, China.
Zhang Y; Department of Immunology, Hebei Medical University, Shijiazhuang, Hebei, China.; Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Shijiazhuang, Hebei, China.
Li M; Department of Immunology, Hebei Medical University, Shijiazhuang, Hebei, China.; Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Shijiazhuang, Hebei, China.
Al-Shaebi F; Department of Immunology, Hebei Medical University, Shijiazhuang, Hebei, China.; Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Shijiazhuang, Hebei, China.
Li J; Department of Immunology, Hebei Medical University, Shijiazhuang, Hebei, China.; Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Shijiazhuang, Hebei, China.; Department of Pathogen Biology, Hebei Medical University, Shijiazhuang, Hebei, China.
Zhang J; Department of Immunology, Hebei Medical University, Shijiazhuang, Hebei, China.; Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Shijiazhuang, Hebei, China.
Wei L; Department of Immunology, Hebei Medical University, Shijiazhuang, Hebei, China.; Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Shijiazhuang, Hebei, China.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2021 Jul 12; Vol. 95 (15), pp. e0056321. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cyclophilin A/*genetics
Cyclophilin A/*metabolism
Peptidylprolyl Isomerase/*metabolism
Respiratory Syncytial Virus, Human/*growth & development
Virus Replication/*physiology
Animals ; Cell Line ; Chlorocebus aethiops ; Female ; Humans ; Mass Spectrometry ; Mice ; Mice, Inbred BALB C ; RNA Interference ; RNA, Small Interfering/genetics ; Respiratory Syncytial Virus Infections/pathology ; Ribonucleoproteins/metabolism ; Vero Cells ; Viral Nonstructural Proteins/metabolism ; Viral Proteins/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies